Valuation: Celularity Inc.

Market Cap 22.58M 19.84M 18.44M 16.96M 31.8M 2.18B 32.4M 220M 85.88M 1.06B 84.75M 82.93M 3.7B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 91.12M 80.08M 74.41M 68.43M 128M 8.8B 131M 887M 347M 4.3B 342M 335M 14.93B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.82%
Yield 2024 *
-
Yield 2025 -
1 day-2.56%
1 week-2.56%
Current month+27.11%
1 month+0.26%
3 months-35.04%
6 months-40.39%
Current year-31.53%
1 week 0.75
Extreme 0.75
0.84
1 month 0.56
Extreme 0.5601
0.86
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 01/01/2016
Director of Finance/CFO 67 27/02/2026
Compliance Officer 42 01/07/2021
Director TitleAgeSince
Chairman 66 01/01/2016
Director/Board Member 64 01/07/2017
Director/Board Member 73 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
19/06/26 Other 2,043,979 7.0614%
19/06/26 Other 2,043,979 7.0614%
19/06/26 Other 2,043,979 7.0614%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-2.56%-79.68%-86.50% 22.58M
+0.11%-1.89%+16.22%-11.26% 66.25B
-0.12%+3.10%+40.83%+196.27% 52.86B
+0.51%+37.90%+37.90%+37.90% 43.01B
-1.86%-4.93%-56.15%-56.66% 39.52B
+1.46%+1.71%+56.92%-27.51% 29.19B
+0.78%+1.39%+69.36%+81.90% 23.13B
-1.81%-16.49%+74.21%-54.90% 23.04B
-1.30%-6.18%+3.94%+177.59% 20.48B
-1.04%+0.53%+69.40%+119.96% 16.6B
Average -0.47%-1.90%+23.30%+37.68% 31.41B
Weighted average by Cap. -0.16%-1.59%+28.18%+46.08%

Financials

2024 2025
Net sales 54.22M 47.65M 44.28M 40.72M 76.37M 5.24B 77.82M 528M 206M 2.56B 204M 199M 8.88B 26.55M 23.33M 21.68M 19.94M 37.39M 2.56B 38.11M 259M 101M 1.25B 99.66M 97.52M 4.35B
Net income -57.89M -50.88M -47.28M -43.48M -81.54M -5.59B -83.09M -564M -220M -2.73B -217M -213M -9.48B -91.72M -80.61M -74.9M -68.88M -129M -8.86B -132M -893M -349M -4.32B -344M -337M -15.02B
Net Debt 68.1M 59.85M 55.61M 51.15M 95.91M 6.58B 97.74M 663M 259M 3.21B 256M 250M 11.16B 68.54M 60.24M 55.97M 51.48M 96.53M 6.62B 98.37M 668M 261M 3.23B 257M 252M 11.23B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
23/07/26 $0.7711 -1.14% 78,224
22/07/26 $0.7800 -3.70% 21,464
21/07/26 $0.8100 +3.85% 11,904
20/07/26 $0.7800 -0.04% 7,610
17/07/26 $0.7803 +1.59% 16,925

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock